Background Image
Table of Contents Table of Contents
Previous Page  66 / 64 Next Page
Basic version Information
Show Menu
Previous Page 66 / 64 Next Page
Page Background

66

José Manuel Muñoz Olmedo

Basics of isolation and cultivation of chondrocytes

INTRODUCTION

Cartilage tissue is composed of chondrocytes embedded

within a dense extracellular matrix (ECM). It has poor

autonomous regeneration capacity, mainly due to its avascular

nature. Another factor contributing to poor regenerative

capacity of articular cartilage (AC) is the restricted number

of ECM producing cells. The percentage of highly specialized

chondrocytes in cartilage tissue is only 1–3% (1). Chondrocytes

are unable to migrate to a site of injury; they are able to

synthesize fibrous repair tissue, but not sufficiently to fill

even small defects (<3 mm in diameter) with a cartilage-like

matrix, the defects are not repaired and remains permanently

(2). Cartilage was used as one of the first models for research

of

in vitro

engineered tissues and has shown the earliest

application for the cell-based therapy mainly due to its cellular

homogeneity and avascularity (3).

Chondrocytes within their natural environment actively

synthesize and maintain their surrounding matrix. Mature

chondrocytes have limited ability to proliferate; they are often

mislabeled as dormant. In cell culture, human chondrocytes

regain their ability to proliferate. Thus, the basic premise

behind Autologous Chondrocyte Implantation (ACI) is to

overcome the inherent limitations of mature chondrocytes to

effectively restore an injured articular surface.

In monolayer culture, these cells respond by undergoing

rapid proliferation. Histologically, these chondrocytes reversibly

dedifferentiate, assuming a fibroblastic appearance and express

type I collagen as opposed to type II collagen normally seen in

articular cartilage. Once removed from the monolayer culture

and placed in suspension or returned to the articular cartilage

environment, the cells undergo a re-differentiation process

into normal appearing chondrocytes and again produce type II

collagen and proteoglycan aggregates (4).

In 1994 Brittberg

et al

described the use of ACI in treating

full-thickness AC defects of the human knee (5). It was achieved

in a two-stage procedure. Stage 1 involved arthroscopic biopsy

of healthy AC and cultivation of the chondrocytes to produce

between 5 and 10 million cells over a period of 4–6 weeks.

Stage 2 involved debridement of the osteochondral lessions

and coverage by a periosteal flap followed by open implantation

of these cells into the AC defect.

Isolation and cultivation of chondrocytes is a widely spread

technique.ItisrequiredinACIasatreatmentforostheochondritis

dissecans (6), ostheoarthritis (7) and articular cartilage injuries

produced by trauma (8). In general, it can be used in any

articular cartilage injury, where other surgical procedures are

not sufficient (4).

In vitro

chondrocyte manipulation is a crucial

phase of autologous chondrocyte implantation. To minimize

the risk of

in vitro

cell contamination, the manipulation must

be performed in a controlled environment such as a cleanroom

according to good laboratory practice (GLP). The GLP standards

provide guidance on implementing GLP requirements critical

for laboratory operations (9, 10).

In the current study, we have used basic methods

for isolation and cultivation of chondrocytes from human

articular cartilage according to GLP standards. Phenotype

characterization of chondrocytes was performed by flow

cytometry analysis.

MATERIALS AND METHODS

Work in cleanroom according to GLP standards

Isolation and cultivation of chondrocytes was performed

in the cleanroom in Associated Tissue Bank of Faculty of

Medicine of P. J. Šafárik University and L. Pasteur University

Hospital in Košice, Slovakia. A cleanroom is a controlled

environment in which the concentration of airborne particles is

controlled to specified limits (Tab.1). Contaminants generated

by people, process, facilities and equipment were continually

removed from the air. Air flow rates, direction, pressurization,

temperature, humidity and specialized filtration were all

tightly controlled. Persons and materials entered and exited

the cleanroom through airlocks (material pass box), gowning

rooms and they weared special clothing designed to trap

contaminants that are naturally generated by skin and the

body. Cells were handled inside biological safety cabinets and

cultivated in the gas incubators (Fig. 1).

Isolation and cultivation of chondrocytes

Human cartilage tissue was harvested from the lateral

femoral condyle of 5 patients (an average age: 63 years)

undergoing total knee replacement surgery due to osteoarthritis

(stage 3). Cartilage tissue was harvested in accordance with the

ethical standards of L. Pasteur University Hospital commitee

on human experimentation in Košice, Slovakia. Cartilage

tissue was placed into the transport medium containing sterile

high-glucose Dulbecco’s modified Eagle medium (DMEM;

Invitrogen, GIBCO, USA) supplemented with 1% antibiotic/

antimycotic solution (10,000 units/mL penicillin, 10,000

µ

g/mL

streptomycin, and 25

µ

g/mL amphotericin B; Invitrogen, GIBCO,

USA). Cartilage tissue was minced with a scalpel to small pieces

(1x1x1 mm) and digested with 0,1% bacterial collagenase type

II (Invitrogen, GIBCO, USA) in Ham’s F-12 (Biochrom AG) for

20 h at 37 C in 95% air and 5% CO

2

humified atmosphere. Cell

suspension was filtered by 40

µ

m nylon cell strainer (BD Falcon,

Biosciences, Bedford, MA) to remove cell raft and matrix debris.

The filtrate was then centrifuged at 150 x g for 7 min and the

pellet washed twice with DMEM (Invitrogen, GIBCO, USA).

Isolated cells were suspended in cell culture medium containing

Ham’s F-12 (Biochrom AG), 10% fetal bovine serum (FBS;

Invitrogen, GIBCO, USA), 1% antibiotic/antimycotic solution

(10,000 units/mL penicillin, 10,000

µ

g/mL streptomycin, and 25

µ

g/mL amphotericin B; Invitrogen, GIBCO, USA) and 1% Insulin-

Transferin-Selenium–A supplement (Invitrogen, GIBCO, USA).

Chondrocytes were cultivated as a monolayer for expansion in

37 C humidified incubator with an atmosphere of 95% air and

5% CO

2

. The medium was changed 2 times weekly. Confluent

layers of chondrocytes were dissociated with 0.05% Trypsin-

EDTA solution (Invitrogen, GIBCO®, USA) and the number

and viability of cells was assessed by TC10™ Automated Cell

Counter (Bio-Rad Laboratories).

Characterization of chondrocytes

Fig. 1.

Cleanroom facilities for cell cultivation according to GLP

standards